GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Atara Biotherapeutics Inc (LTS:0HIY) » Definitions » E10

Atara Biotherapeutics (LTS:0HIY) E10 : $-98.68 (As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Atara Biotherapeutics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Atara Biotherapeutics's adjusted earnings per share data for the three months ended in Dec. 2024 was $-1.190. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-98.68 for the trailing ten years ended in Dec. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-03-14), Atara Biotherapeutics's current stock price is $6.8448. Atara Biotherapeutics's E10 for the quarter that ended in Dec. 2024 was $-98.68. Atara Biotherapeutics's Shiller PE Ratio of today is .


Atara Biotherapeutics E10 Historical Data

The historical data trend for Atara Biotherapeutics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atara Biotherapeutics E10 Chart

Atara Biotherapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -92.94 -116.05 -98.68

Atara Biotherapeutics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -116.05 -102.97 -106.78 -106.75 -98.68

Competitive Comparison of Atara Biotherapeutics's E10

For the Biotechnology subindustry, Atara Biotherapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Atara Biotherapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Atara Biotherapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Atara Biotherapeutics's Shiller PE Ratio falls into.



Atara Biotherapeutics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Atara Biotherapeutics's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-1.19/133.1571*133.1571
=-1.190

Current CPI (Dec. 2024) = 133.1571.

Atara Biotherapeutics Quarterly Data

per share eps CPI Adj_EPS
201503 -10.500 99.621 -14.035
201506 -15.500 100.684 -20.499
201509 -10.750 100.392 -14.259
201512 -18.750 99.792 -25.019
201603 -14.500 100.470 -19.217
201606 -16.500 101.688 -21.606
201609 -22.000 101.861 -28.759
201612 -15.750 101.863 -20.589
201703 -22.000 102.862 -28.479
201706 -23.500 103.349 -30.278
201709 -25.500 104.136 -32.607
201712 -28.750 104.011 -36.806
201803 -26.250 105.290 -33.198
201806 -28.750 106.317 -36.008
201809 -32.250 106.507 -40.320
201812 -43.750 105.998 -54.960
201903 -36.000 107.251 -44.696
201906 -40.000 108.070 -49.286
201909 -32.750 108.329 -40.256
201912 -34.000 108.420 -41.757
202003 -30.000 108.902 -36.682
202006 -28.500 108.767 -34.891
202009 -23.000 109.815 -27.889
202012 -23.750 109.897 -28.777
202103 -21.500 111.754 -25.618
202106 -22.750 114.631 -26.427
202109 -22.500 115.734 -25.887
202112 -24.000 117.630 -27.168
202203 -21.750 121.301 -23.876
202206 4.500 125.017 4.793
202209 -20.500 125.227 -21.798
202212 -18.000 125.222 -19.141
202303 -18.000 127.348 -18.821
202306 -16.910 128.729 -17.492
202309 -16.400 129.860 -16.816
202312 -13.920 129.419 -14.322
202403 -5.750 131.776 -5.810
202406 -3.100 132.554 -3.114
202409 -2.930 133.029 -2.933
202412 -1.190 133.157 -1.190

Add all the adjusted EPS together and divide 10 will get our e10.


Atara Biotherapeutics  (LTS:0HIY) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Atara Biotherapeutics E10 Related Terms

Thank you for viewing the detailed overview of Atara Biotherapeutics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Atara Biotherapeutics Business Description

Traded in Other Exchanges
Address
2380 Conejo Spectrum Street, Suite 200, Thousand Oaks, CA, USA, 91320
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

Atara Biotherapeutics Headlines

No Headlines